Women and HIV: Closing the treatment gap

Lisa Hirschhorn*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A greater susceptibility to the adverse effects of protease inhibitors is just one of many possible reasons that highly active antiretroviral therapy has been less beneficial in women. How can you ensure that treatment is optimal?

Original languageEnglish (US)
Pages (from-to)187-201
Number of pages15
JournalPatient Care
Volume33
Issue number6
StatePublished - Mar 30 1999

ASJC Scopus subject areas

  • Leadership and Management

Fingerprint Dive into the research topics of 'Women and HIV: Closing the treatment gap'. Together they form a unique fingerprint.

Cite this